Assessing Compliance Risks Around TrumpRx Participation

By Dominick DiSabatino, Scott Liebman and Julian Klein
February 12, 2026, 6:22 PM EST

The genesis of the first direct-to-consumer drug concept in the U.S. is debated....

Already a subscriber? Click here to view full article